Vitamin E Supplements in Asthma: a Parallel Group Randomised Placebo Controlled Trial
Overview
Authors
Affiliations
Background: Increased dietary vitamin E intake is associated with a reduced incidence of asthma, and combinations of antioxidant supplements including vitamin E are effective in reducing ozone induced bronchoconstriction. A study was undertaken to investigate the effect of supplementation with vitamin E for 6 weeks on bronchial hyperresponsiveness in atopic adults with asthma.
Methods: 72 participants from a clinical trial register of adults with asthma were randomised to receive 500 mg natural vitamin E or matched placebo for 6 weeks in a placebo controlled, double blind parallel group clinical trial. Inclusion criteria included age 18-60 years, maintenance treatment of at least one dose of inhaled corticosteroid per day, a positive skin prick test to one of three common allergens, and bronchial hyperresponsiveness to methacholine (defined as a dose provoking a 20% fall in forced expiratory volume in 1 second (FEV(1)) (PD(20)) of 12.25 micromol). Secondary outcomes were FEV(1), forced vital capacity, mean morning and evening peak flow, symptom scores, bronchodilator use, and serum immunoglobulin E levels.
Results: In the primary intention to treat analysis the change in PD(20) was similar in the vitamin E and placebo groups with a mean difference of +0.25 doubling doses of methacholine (95% confidence interval -0.67 to +1.16 greater with vitamin E). There was no effect of vitamin E supplementation on any other measure of asthma control, either in the intention to treat or per protocol analysis. There was also no effect of vitamin E supplementation on serum immunoglobulin levels.
Conclusion: Dietary supplementation with vitamin E adds no benefit to current standard treatment in adults with mild to moderate asthma.
Arabi V, Sasanfar B, Toorang F, Nafei Z, Behniafard N, Salehi-Abargouei A BMC Nutr. 2024; 10(1):92.
PMID: 38937858 PMC: 11210139. DOI: 10.1186/s40795-024-00884-4.
Listyoko A, Okazaki R, Harada T, Takata M, Morita M, Ishikawa H Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931379 PMC: 11206512. DOI: 10.3390/ph17060712.
Nutrient synergy: definition, evidence, and future directions.
Townsend J, Kirby T, Sapp P, Gonzalez A, Marshall T, Esposito R Front Nutr. 2023; 10:1279925.
PMID: 37899823 PMC: 10600480. DOI: 10.3389/fnut.2023.1279925.
A Review on Natural Antioxidants for Their Role in the Treatment of Parkinson's Disease.
Mittal P, Dhankhar S, Chauhan S, Garg N, Bhattacharya T, Ali M Pharmaceuticals (Basel). 2023; 16(7).
PMID: 37513820 PMC: 10385773. DOI: 10.3390/ph16070908.
Farooq S, Khatri S Adv Exp Med Biol. 2023; 1426:43-76.
PMID: 37464116 DOI: 10.1007/978-3-031-32259-4_3.